Article

Insights on microbial keratitis risk post-LVC

Results of a retrospective analysis of more than 432,000 eyes that underwent LASIK or photorefractive keratectomy (PRK) as a primary procedure show a very low rate of postoperative microbial keratitis, said Julie Schallhorn, MD, MS.

 

Portland, OR-Results of a retrospective analysis of more than 432,000 eyes that underwent LASIK or photorefractive keratectomy (PRK) as a primary procedure show a very low rate of postoperative microbial keratitis, said Julie Schallhorn, MD, MS.

“Microbial keratitis is a potentially devastating complication of laser vision refractive surgery,” said Dr. Schallhorn, cornea fellow, Casey Eye Institute, Oregon Health and Science University, Portland.

The eyes included in the study were operated on between January 2008 and December 2012 at the 25 Optical Express centers in the United Kingdom. All of the patients received standard antibiotic prophylaxis that consisted of four times daily topical fluoroquinolone (ofloxacin), which was continued for 1 week after LASIK and until complete re-epithelialization and bandage contact lens removal following PRK.

Suspected microbial keratitis based on slit lamp appearance was diagnosed in 57 eyes (0.013%) of 54 patients. About three-fourths of the eyes with microbial keratitis had a final best-corrected visual acuity (BCVA) of 20/20 or better, and BCVA was 20/40 or better in about 88%.

 

Analyses to determine variables associated with development of microbial keratitis showed the risk of infection was significantly higher among hyperopes compared with myopes, with PRK compared with LASIK, and when using a mechanical keratome for LASIK flap creation versus a femtosecond laser.

Hyperopes undergoing PRK had a 6-fold greater risk of suspected microbial keratitis compared to a myope undergoing LASIK with femtosecond laser flap creation.

All eyes with suspected microbial keratitis were cultured, although not all culture data could be obtained because of United Kingdom privacy laws. Among 12 culture-positive cases that could be reviewed, methicillin-resistant Staphylococcus aureus was the most common isolate (33%). There were two cases each of methicillin-susceptible S. aureus and Mycobacterium chelonae infection and a fungal pathogen was isolated in four eyes.

“The results of our study representing a large refractive surgery population are consistent with previous reports and reassuring in showing that the risk appears to be low,” Dr. Schallhorn explained. “In addition, we believe this is the first study to provide information comparing the rate of microbial keratitis after LASIK versus PRK and to analyze potential risk factors.

 

“This information may be useful when counseling potential refractive surgery candidates,” she said.

 

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.